[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Medical Polymers-Global Market Status and Trend Report 2013-2023

November 2017 | 147 pages | ID: M131E2E1CB2EN
MIReports Co., Limited

US$ 2,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Report Summary

Medical Polymers-Global Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Medical Polymers industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:

Worldwide and Regional Market Size of Medical Polymers 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Medical Polymers worldwide, with company and product introduction, position in the Medical Polymers market
Market status and development trend of Medical Polymers by types and applications
Cost and profit status of Medical Polymers, and marketing status
Market growth drivers and challenges

The report segments the global Medical Polymers market as:

Global Medical Polymers Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023)

North America
Europe
China
Japan
Rest APAC
Latin America

Global Medical Polymers Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):

Medical resins and fibers
Medical elastomers
Biodegradable plastics
Other

Global Medical Polymers Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)

Medical devices and equipment
Medical packaging
Others (Including tissue engineering and cardio stents)

Global Medical Polymers Market: Manufacturers Segment Analysis (Company and Product introduction, Medical Polymers Sales Volume, Revenue, Price and Gross Margin):

BASF SE
Bayer
Celanese
DSM
Du Pont
Solvay
Eastman Chemical
Evonik
HEXPOL
Exxon Mobil
Formosa Plastics
INEOS
Dow
Victrex
Colorite Compounds?
Raumedic
Kraton
Tianjin Plastics
Shanghai New Shanghua

In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF MEDICAL POLYMERS

1.1 Definition of Medical Polymers in This Report
1.2 Commercial Types of Medical Polymers
  1.2.1 Medical resins and fibers
  1.2.2 Medical elastomers
  1.2.3 Biodegradable plastics
  1.2.4 Other
1.3 Downstream Application of Medical Polymers
  1.3.1 Medical devices and equipment
  1.3.2 Medical packaging
  1.3.3 Others (Including tissue engineering and cardio stents)
1.4 Development History of Medical Polymers
1.5 Market Status and Trend of Medical Polymers 2013-2023
  1.5.1 Global Medical Polymers Market Status and Trend 2013-2023
  1.5.2 Regional Medical Polymers Market Status and Trend 2013-2023

CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS

2.1 Market Development of Medical Polymers 2013-2017
2.2 Production Market of Medical Polymers by Regions
  2.2.1 Production Volume of Medical Polymers by Regions
  2.2.2 Production Value of Medical Polymers by Regions
2.3 Demand Market of Medical Polymers by Regions
2.4 Production and Demand Status of Medical Polymers by Regions
  2.4.1 Production and Demand Status of Medical Polymers by Regions 2013-2017
  2.4.2 Import and Export Status of Medical Polymers by Regions 2013-2017

CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES

3.1 Production Volume of Medical Polymers by Types
3.2 Production Value of Medical Polymers by Types
3.3 Market Forecast of Medical Polymers by Types

CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY

4.1 Demand Volume of Medical Polymers by Downstream Industry
4.2 Market Forecast of Medical Polymers by Downstream Industry

CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF MEDICAL POLYMERS

5.1 Global Economy Situation and Trend Overview
5.2 Medical Polymers Downstream Industry Situation and Trend Overview

CHAPTER 6 MEDICAL POLYMERS MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS

6.1 Production Volume of Medical Polymers by Major Manufacturers
6.2 Production Value of Medical Polymers by Major Manufacturers
6.3 Basic Information of Medical Polymers by Major Manufacturers
  6.3.1 Headquarters Location and Established Time of Medical Polymers Major Manufacturer
  6.3.2 Employees and Revenue Level of Medical Polymers Major Manufacturer
6.4 Market Competition News and Trend
  6.4.1 Merger, Consolidation or Acquisition News
  6.4.2 Investment or Disinvestment News
  6.4.3 New Product Development and Launch

CHAPTER 7 MEDICAL POLYMERS MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA

7.1 BASF SE
  7.1.1 Company profile
  7.1.2 Representative Medical Polymers Product
  7.1.3 Medical Polymers Sales, Revenue, Price and Gross Margin of BASF SE
7.2 Bayer
  7.2.1 Company profile
  7.2.2 Representative Medical Polymers Product
  7.2.3 Medical Polymers Sales, Revenue, Price and Gross Margin of Bayer
7.3 Celanese
  7.3.1 Company profile
  7.3.2 Representative Medical Polymers Product
  7.3.3 Medical Polymers Sales, Revenue, Price and Gross Margin of Celanese
7.4 DSM
  7.4.1 Company profile
  7.4.2 Representative Medical Polymers Product
  7.4.3 Medical Polymers Sales, Revenue, Price and Gross Margin of DSM
7.5 Du Pont
  7.5.1 Company profile
  7.5.2 Representative Medical Polymers Product
  7.5.3 Medical Polymers Sales, Revenue, Price and Gross Margin of Du Pont
7.6 Solvay
  7.6.1 Company profile
  7.6.2 Representative Medical Polymers Product
  7.6.3 Medical Polymers Sales, Revenue, Price and Gross Margin of Solvay
7.7 Eastman Chemical
  7.7.1 Company profile
  7.7.2 Representative Medical Polymers Product
  7.7.3 Medical Polymers Sales, Revenue, Price and Gross Margin of Eastman Chemical
7.8 Evonik
  7.8.1 Company profile
  7.8.2 Representative Medical Polymers Product
  7.8.3 Medical Polymers Sales, Revenue, Price and Gross Margin of Evonik
7.9 HEXPOL
  7.9.1 Company profile
  7.9.2 Representative Medical Polymers Product
  7.9.3 Medical Polymers Sales, Revenue, Price and Gross Margin of HEXPOL
7.10 Exxon Mobil
  7.10.1 Company profile
  7.10.2 Representative Medical Polymers Product
  7.10.3 Medical Polymers Sales, Revenue, Price and Gross Margin of Exxon Mobil
7.11 Formosa Plastics
  7.11.1 Company profile
  7.11.2 Representative Medical Polymers Product
  7.11.3 Medical Polymers Sales, Revenue, Price and Gross Margin of Formosa Plastics
7.12 INEOS
  7.12.1 Company profile
  7.12.2 Representative Medical Polymers Product
  7.12.3 Medical Polymers Sales, Revenue, Price and Gross Margin of INEOS
7.13 Dow
  7.13.1 Company profile
  7.13.2 Representative Medical Polymers Product
  7.13.3 Medical Polymers Sales, Revenue, Price and Gross Margin of Dow
7.14 Victrex
  7.14.1 Company profile
  7.14.2 Representative Medical Polymers Product
  7.14.3 Medical Polymers Sales, Revenue, Price and Gross Margin of Victrex
7.15 Colorite Compounds?
  7.15.1 Company profile
  7.15.2 Representative Medical Polymers Product
  7.15.3 Medical Polymers Sales, Revenue, Price and Gross Margin of Colorite Compounds?
7.16 Raumedic
7.17 Kraton
7.18 Tianjin Plastics
7.19 Shanghai New Shanghua

CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF MEDICAL POLYMERS

8.1 Industry Chain of Medical Polymers
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis

CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF MEDICAL POLYMERS

9.1 Cost Structure Analysis of Medical Polymers
9.2 Raw Materials Cost Analysis of Medical Polymers
9.3 Labor Cost Analysis of Medical Polymers
9.4 Manufacturing Expenses Analysis of Medical Polymers

CHAPTER 10 MARKETING STATUS ANALYSIS OF MEDICAL POLYMERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

CHAPTER 11 REPORT CONCLUSION

CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE

12.1 Methodology/Research Approach
  12.1.1 Research Programs/Design
  12.1.2 Market Size Estimation
  12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
  12.2.1 Secondary Sources
  12.2.2 Primary Sources
12.3 Reference


More Publications